Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Return on Equity (2016 - 2025)

Ironwood Pharmaceuticals' Return on Equity history spans 15 years, with the latest figure at 0.21% for Q4 2025.

  • For Q4 2025, Return on Equity rose 22.0% year-over-year to 0.21%; the TTM value through Dec 2025 reached 0.21%, up 22.0%, while the annual FY2025 figure was 0.41%, 41.0% down from the prior year.
  • Return on Equity for Q4 2025 was 0.21% at Ironwood Pharmaceuticals, up from 0.1% in the prior quarter.
  • Across five years, Return on Equity topped out at 2.72% in Q3 2023 and bottomed at 4.88% in Q2 2023.
  • The 5-year median for Return on Equity is 0.35% (2022), against an average of 0.07%.
  • The largest annual shift saw Return on Equity tumbled -521bps in 2023 before it soared 555bps in 2024.
  • A 5-year view of Return on Equity shows it stood at 0.89% in 2021, then plummeted by -57bps to 0.39% in 2022, then plummeted by -731bps to 2.44% in 2023, then surged by 100bps to 0.0% in 2024, then skyrocketed by 7021bps to 0.21% in 2025.
  • Per Business Quant, the three most recent readings for IRWD's Return on Equity are 0.21% (Q4 2025), 0.1% (Q3 2025), and 0.02% (Q2 2025).